The CDC, Centers for Disease Control and Prevention, is endorsing the Advisory Committee on Immunization Practices’ (ACIP) recommendation to expand eligibility of booster doses to those 12- to 15-years-old. CDC now recommends that adolescents age 12- to 17-years-old should receive a booster shot five months after their initial Pfizer-BioNTech vaccination series.
Data show that COVID-19 boosters help broaden and strengthen protection against Omicron and other SARS-CoV-2 variants. ACIP reviewed the available safety data following the administration of over 25 million vaccine doses in adolescents; COVID-19 vaccines are safe and effective.
At this time, only the Pfizer-BioNTech COVID-19 vaccine is authorized and recommended for adolescents aged 12 through 17.
“It is critical that we protect our children and teens from COVID-19 infection and the complications of severe disease,” said CDC Director, Dr. Rochelle Walensky. “I endorsed ACIP’s vote to expand eligibility and strengthen our recommendations for booster doses. We now recommend that all adolescents aged 12 to 17 years should receive a booster shot five months after their primary series. This booster dose will provide optimized protection against COVID-19 and the Omicron variant. I encourage all parents to keep their children up to date with CDC’s COVID-19 vaccine recommendations.”